NCT00676949View on ClinicalTrials.gov

Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Metastatic Tumors
Interventions
BIOLOGICAL

5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1

1mg each of 5 peptides with IFA. 4 weekly s.c. administration.

Trial Locations (1)

812-8582

Kyushu University Hospital, Fukuoka

All Listed Sponsors
collaborator

Human Genome Center, Institute of Medical Science, University of Tokyo

OTHER

lead

Kyushu University

OTHER

NCT00676949 - Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors | Biotech Hunter | Biotech Hunter